众生药业盐酸氨溴索口服溶液获药品注册证书

Core Viewpoint - Guangdong Zhongsheng Pharmaceutical Co., Ltd. has received approval from the National Medical Products Administration for the registration of its oral solution of Ambroxol Hydrochloride, which is indicated for the treatment of bronchitis-related symptoms [2] Group 1 - The approved product, Ambroxol Hydrochloride oral solution, is suitable for both acute and chronic bronchitis, specifically addressing issues related to thick phlegm and difficulty in expectoration [2] - The announcement highlights that there are clear clinical guidelines recommending the use of this medication for the specified conditions [2]